VeGen Labs Receives Rs 3.765 Crores in BIRAC Funding to Develop KRAS Inhibitor for Non-Small Cell Lung CancerMarch 8, 2025 VeGen Labs, a biotechnology startup based at the University of Hyderabad, has secured significant funding to advance its research towards a KRAS inhibitor for the treatment of non-small cell lung cancer.
